1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Patient Preference: new trials by email Literature Review of Patient Preference trials Research Report on Patient Preference
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer Apalutamide, Enzalutamide - Prostate Cancer | Phase 3 | Terminated | Chinese University of Hong Kong | 74 | 2020-07-20 | 2026-10-27 |
Behavior (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Health Behavior (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Patient Satisfaction (1) · Prostatic Diseases (1) · Treatment Adherence and Compliance (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1)
apalutamide (1) · enzalutamide (1)
Chinese University of Hong Kong (1)
Hong Kong (1)
Chi Fai NG, MD (1)